GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » Change In Receivables

Genotech (XKRX:066830) Change In Receivables : ₩-30 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Genotech Change In Receivables?

Genotech's change in receivables for the quarter that ended in Dec. 2023 was ₩-30 Mil. It means Genotech's Accounts Receivable increased by ₩30 Mil from Dec. 2022 to Dec. 2023 .

Genotech's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-30 Mil. It means Genotech's Accounts Receivable increased by ₩30 Mil from Dec. 2022 to Dec. 2023 .

Genotech's Accounts Receivable for the quarter that ended in Dec. 2023 was ₩110 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Genotech's Days Sales Outstanding for the six months ended in Dec. 2023 was 7.31.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Genotech's liquidation value for the six months ended in Dec. 2023 was ₩5,364 Mil.


Genotech Change In Receivables Historical Data

The historical data trend for Genotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech Change In Receivables Chart

Genotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only 439.08 -80.96 -909.85 1,128.65 -30.49

Genotech Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only 439.08 -80.96 -909.85 1,128.65 -30.49

Genotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genotech  (XKRX:066830) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Genotech's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=110.109/2750.326*91
=7.31

2. In Ben Graham's calculation of liquidation value, Genotech's accounts receivable are only considered to be worth 75% of book value:

Genotech's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=5993.516-778.719+0.75 * 110.109+0.5 * 133.359
=5,364

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Genotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Genotech (XKRX:066830) Business Description

Traded in Other Exchanges
N/A
Address
26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343
Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech (XKRX:066830) Headlines

No Headlines